The Crawford Resignation Mystery Sat, 24 Sep 2005 Merrill Goozner of Center for Science in the Public Interest provides insight into what may lie behind the sudden resignation of FDA Commissioner, Lester Crawford. Goozner surggests, “One possible clue to the administration’s thinking comes from the appointment of Andrew von Eschenbach,…
What the FDA Isn’t Telling You – SLATE Date: Tue, 27 Sep 2005 Writing in SLATE, Jeanne Lenzer has uncovered evidence demonstrating FDA culpability in helping drug manufacturers conceal vital, life-saving information from the public. In this case, undisclosed suicides in clinical trials testing Eli Lilly’s drug, duloxetine (trade names:…
TIME inquiry finds top officials at vital gov agencies lack credentials for the job Date: Wed, 28 Sep 2005 The New York Times reports today that the mystery of Lester Crawford’s abrupt resignation as head of the FDA “fueled speculation that he had investments in companies regulated by the FDA."…
On Evidence, Medical and Legal Mon, 5 Sep 2005 An outstanding highly recommended article by a physician and an attorney, On Evidence, Medical and Legal by DonaldW. Miller, Jr., M.D. and Clifford G. Miller, Esq. clearly lays out the standards of evidence law in medicine. The authors critique the courts’…
Guidant Case May Involve Crime Inquiry Thu, 29 Sep 2005 The New York Times reports that “criminal investigators at the Food and Drug Administration have apparently become involved in the agency’s inquiry into how the Guidant Corporation handled problems with its heart devices, said two people contacted by the investigators."…
SC Supreme Court To Hear Christopher Pittman Appeal Thu, 1 Sep 2005 This just in from Miracles Of Hope Network New York – Chicago – Paris – Hollywood – Washington DC – Atlanta – Las Vegas The South Carolina Supreme Court has by-passed the Court of Appeals and will hear…
Doctor Chides Medical Societies to Take Action – GSK Fined $150 Million in Medicare Fraud Wed, 21 Sep 2005 The latest in a series of fraud settlements, GlaxoSmithKline has agreed to pay $150 million to settle fraud allegations over inflating price of Zorfran and Kytril (nausea drugs) when billing Medicare…
$95 billion a year spent on medical research in US – JAMA Fri, 23 Sep 2005 A special issue of the Journal of the American Medical Association, JAMA, focuses on medical research spending and findings. A study that examined US spending for medical research—$95 billion approaching $100 billion–57% is spent…
Phrma found new market for psychotropic drugs: Toledo Zoo Wed, 14 Sep 2005 The Toledo Blade reports: “Now that humans have warmly embraced citizenship in the Prozac Nation, zoo animals are making tentative gallops, flights, and knuckle-walks into the world of psychotropic pharmaceuticals.” However, these drugs have nasty side effects…
Eli Lilly Wants Insurers to Pay $1 billion in Zyprexa claims – AP Tue, 13 Sep 2005 The Associated Press reported that Eli Lilly is trying to pass the buck to insurers– In addition to the $700 million Lilly agreed to pay to settle a lawsuit over the company having…
FDA acknowledges failure to act as defibrillator malfunction increased: 4,225 failed between 2000–2003 Sat, 17 Sep 2005 The Washington Post reports that the number of failed heart defibrillators is increasing: “William H. Maisel, the Harvard Medical School physician who conducted the FDA study, said the increase is significant and contrasts…
Use of combinations of antipsychotics–Harms Patients: McLean & Leipzig Wed, 21 Sep 2005 Two additional studies provide additional evidence (coffin nails) demonstrating how psychiatry’s marriage of convenience gave birth to rotten fruit: specifically, under the influence of pharmaceutical companies, psychiatry plunged irresponsibly into practicing polypsychoparmacology. The evidence from these studies…
